Implement Meta-Analysis with Non-Comparative Binary Data in RevMan Software_Chinese Journal of Evidence-Based Medicine

Authors：

 CHENYue-hong , DULiang , GENGXing-yuan ,  LIUGuan-jian

Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China;

Corresponding?author：

LIUGuan-jian, Email: ceuliu@hotmail.com

Keywords：

Non-comparative; Binary data; RevMan; Stata; Meta-analysis

DOI：

10.7507/1672-2531.20140147

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

This article introduces two methods used to calculate effect indicators and their standard errors with non-comparative binary data. Then we give an example, the effect indicators and standard errors are calculated using both methods, and meta-analysis with the outcomes is conducted using RevMan software. At last the calculated results are compared with the results of meta-analysis conducted using Stata software with original data based on cases. The results of meta-analysis performed in RevMan software and Stata software are consistent in calculating non-comparative binary data.

Citation： CHENYue-hong, DULiang, GENGXing-yuan, LIUGuan-jian. Implement Meta-Analysis with Non-Comparative Binary Data in RevMan Software. Chinese Journal of Evidence-Based Medicine, 2014, 14(7): 889-896. doi: 10.7507/1672-2531.20140147 Copy

1.	凌莉, 韓璐. Meta分析方法的正確應用.循證醫學, 2002, 2(2):102-104.
2.	徐世俠, 湯先華, 陳海青. Meta分析及RevMan軟件介紹.中華醫學圖書情報雜志, 2009, 18(3):61-63.
3.	Glass GV. Primaiy, secondary, and meta-analysis of research. Educational Researcher, 1976, 6(5):3.
4.	曾憲濤, 冷衛東, 郭毅, 等. Meta分析系列之一:Meta分析的類型.中國循證心血管醫學雜志, 2012, 4(1):3-5.
5.	王佩鑫, 李宏田, 劉建蒙.無對照二分類資料的Meta分析方法及Stata實現.循證醫學, 2012, 12(1):52-56.
6.	羅美玲, 譚紅專, 周權, 等.在R軟件中實現單個率的Meta分析.循證醫學, 2013, 13(3):181-185.
7.	宇傳華.參數估計:公式4-11.見:方積乾, 主編.生物醫學研究的統計方法.第1版.北京:高等教育出版社. 2007:65.
8.	Iudici M, Fasano S, Iacono D, et al. Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc):a systematic review and meta-analysis of cohort studies and registries. Clin Rheumatol, 2013, 33(2):153-164.
9.	Hunzelmann N, Moinzadeh P, Genth E, et al. High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy. Arthritis Res Ther, 2009, 11(2):R30.
10.	Mansour S, Bonner A, Muangchan C, et al. Low socioeconomic status (measured by education) and outcomes in systemic sclerosis:data from the Canadian Scleroderma Research Group. J Rheumatol, 2013, 40(4):447-454.
11.	Meier FM, Frommer KW, Dinser R, et al. Update on the profile of the EUSTAR cohort:an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis, 2012, 71(8):1355-1360.
12.	Nikpour M, Hissaria P, Byron J, et al. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis:a cross-sectional analysis of data from an Australian cohort. Arthritis Res Ther, 2011, 13(6):R211.
13.	Vanthuyne M, Smith V, De Langhe E, et al. The Belgian Systemic Sclerosis Cohort:correlations between disease severity scores, cutaneous subsets, and autoantibody profile. J Rheumatol, 2012, 39(11):2127-2133.
14.	衛茂玲, 吳紅梅. RevMan軟件介紹.見:劉鳴, 主編.系統評價、Meta-分析設計與實施方法.第1版.北京:人民衛生出版社. 2012:142-153.
15.	羅杰, 冷衛東.系統評價/Meta分析理論與實踐.第1版.北京:軍事醫學科學出版社. 2013:248-286.
16.	曾憲濤, 李勝, 雷晉, 等. Review Manager 5軟件在診斷準確性實驗的Meta分析中的應用.湖北醫藥學院學報, 2013, 32(1):6-16.

1. 凌莉, 韓璐. Meta分析方法的正確應用.循證醫學, 2002, 2(2):102-104.
2. 徐世俠, 湯先華, 陳海青. Meta分析及RevMan軟件介紹.中華醫學圖書情報雜志, 2009, 18(3):61-63.
3. Glass GV. Primaiy, secondary, and meta-analysis of research. Educational Researcher, 1976, 6(5):3.
4. 曾憲濤, 冷衛東, 郭毅, 等. Meta分析系列之一:Meta分析的類型.中國循證心血管醫學雜志, 2012, 4(1):3-5.
5. 王佩鑫, 李宏田, 劉建蒙.無對照二分類資料的Meta分析方法及Stata實現.循證醫學, 2012, 12(1):52-56.
6. 羅美玲, 譚紅專, 周權, 等.在R軟件中實現單個率的Meta分析.循證醫學, 2013, 13(3):181-185.
7. 宇傳華.參數估計:公式4-11.見:方積乾, 主編.生物醫學研究的統計方法.第1版.北京:高等教育出版社. 2007:65.
8. Iudici M, Fasano S, Iacono D, et al. Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc):a systematic review and meta-analysis of cohort studies and registries. Clin Rheumatol, 2013, 33(2):153-164.
9. Hunzelmann N, Moinzadeh P, Genth E, et al. High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy. Arthritis Res Ther, 2009, 11(2):R30.
10. Mansour S, Bonner A, Muangchan C, et al. Low socioeconomic status (measured by education) and outcomes in systemic sclerosis:data from the Canadian Scleroderma Research Group. J Rheumatol, 2013, 40(4):447-454.
11. Meier FM, Frommer KW, Dinser R, et al. Update on the profile of the EUSTAR cohort:an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis, 2012, 71(8):1355-1360.
12. Nikpour M, Hissaria P, Byron J, et al. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis:a cross-sectional analysis of data from an Australian cohort. Arthritis Res Ther, 2011, 13(6):R211.
13. Vanthuyne M, Smith V, De Langhe E, et al. The Belgian Systemic Sclerosis Cohort:correlations between disease severity scores, cutaneous subsets, and autoantibody profile. J Rheumatol, 2012, 39(11):2127-2133.
14. 衛茂玲, 吳紅梅. RevMan軟件介紹.見:劉鳴, 主編.系統評價、Meta-分析設計與實施方法.第1版.北京:人民衛生出版社. 2012:142-153.
15. 羅杰, 冷衛東.系統評價/Meta分析理論與實踐.第1版.北京:軍事醫學科學出版社. 2013:248-286.
16. 曾憲濤, 李勝, 雷晉, 等. Review Manager 5軟件在診斷準確性實驗的Meta分析中的應用.湖北醫藥學院學報, 2013, 32(1):6-16.

Chinese Journal of Evidence-Based Medicine

Implement Meta-Analysis with Non-Comparative Binary Data in RevMan Software

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content